Roche’s Polivy combination approved by European Commission for people with previously untreated diffuse large B-cell lymphoma May 25, 2022May 25, 2022 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: CHMP recommends EU approval of Roche’s Polivy…FDA accepts supplemental Biologics License…FDA Advisory Committee votes in favour of the…Roche presents new and updated data for Polivy in…FDA accepts supplemental Biologics License…Five-year results confirm Roche’s Polivy combination…
